We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-30.00 | -1.34% | 2,210.00 | 2,170.00 | 2,250.00 | 2,210.00 | 2,210.00 | 2,210.00 | 2,443 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Prepackaged Software | 174.02M | 9.23M | 0.2626 | 84.16 | 776.98M |
TIDMCRW
RNS Number : 0679T
Craneware plc
15 March 2019
Craneware plc
("Craneware" or the "Company")
Dividend Currency Election
15 March 2019 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 5 March 2019.
For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.32.
For further information, please contact:
Craneware plc Peel Hunt Investec Bank Alma (NOMAD & Joint (Joint Broker) (Financial PR) Broker) +44 (0)131 +44 (0)20 7418 +44 (0)20 7597 +44 (0)203 405 550 3100 8900 5970 0212 Keith Neilson, Dan Webster Patrick Robb Caroline Forde CEO Craig Preston, George Sellar Sebastian Lawrence Hilary Buchanan CFO Guy Pengelley Henry Reast Helena Bogle
About Craneware
Craneware develops and provides financial improvement & operational optimisation software that enables US healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCEALDSFLPNEFF
(END) Dow Jones Newswires
March 15, 2019 10:50 ET (14:50 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions